Calixar selected to present at the 5th NovAliX Conference “Biophysics in drug Discovery 2018.
Anass JAWHARI, CSO of CALIXAR will be attending and presenting a new published work (Scientific Reports – Nature) on adenosine receptor (A2A) entitled “Enabling NMR-Based Fragment Screening Using Stabilized Native GPCR” at the 5th NovALIX Conference in Boston in June 2018.
You are welcome to book some time to meet with Anass by contacting him directly at ajawhari@calixar.com.
The fifth edition of the conference intends to bring together biophysicists and medicinal chemists to improve the synergy between their disciplines in order to deliver better drugs on a shorter timeline.